We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 11-20 of 842

IP in depth: patentable biotechnology a comparative analysis of key markets
  • Fisher Adams Kelly Callinans
  • Australia, European Union, New Zealand, USA
  • March 31 2015

There is extraordinary complexity and optimization underlying even comparatively 'simple' organisms. These powerful biological products and processes

Intellectual Property Laws Amendment Act 2015 update on recent changes to Australia’s intellectual property legislation
  • Davies Collison Cave
  • Australia, New Zealand
  • April 15 2015

The Intellectual Property Laws Amendment Act 2015 (Cth) received Royal Assent on 25 February 2015. Although some changes under the Act came into

Opportunity to make submissions on Natural Health and Supplementary Products Bill
  • AJ Park
  • New Zealand
  • November 18 2016

New Zealand's Natural Health and Supplementary Products Bill has been held up again, with Parliament extending the deadlines for submitting on aspects

Employee unjustifiably dismissed after producing suspicious medical certificate
  • Bell Gully
  • New Zealand
  • July 23 2014

The Employment Court recently held that the dismissal by Telecom of an employee who produced a suspicious medical certificate after he failed to

Residential care provider unable to recover fees because of poor admission agreement and execution process
  • Buddle Findlay
  • New Zealand
  • December 6 2013

The High Court has found that a mother is not liable for the residential care fees for her intellectually disabled and terminally ill son, because

Registration cancelled for a "prolonged sequence of egregious professional breaches"
  • Buddle Findlay
  • New Zealand
  • December 6 2013

A psychiatrist who entered into a sexual relationship with a vulnerable patient, continued with the intimate and exploitative relationship after

Patents covering microorganisms-new deposit receipt requirements in New Zealand
  • Shelston IP Pty Ltd
  • New Zealand
  • September 30 2014

When a claim of a patent covers a micro-organism that is difficult to reproduce or a method that requires the use of such a micro-organism, the

Here we go again...the next steps towards the new health and safety legislation
  • Hesketh Henry
  • New Zealand
  • July 30 2015

After some 16 months of consideration, 226 submissions, and 2 extensions, the Transport and Industrial Relations Select Committee has finally

PfizerHospira merger - Green light from New Zealand Commerce Commission to go with EU approval
  • DLA Piper LLP
  • European Union, New Zealand, USA
  • December 1 2015

As the deal is reviewed by the Federal Trade Commission in the US, the New Zealand Commerce Commission has cleared the acquisition by Pfizer Inc. to

Pharmaceutical patent term extension and data exclusivity in Australia, New Zealand and Asia: are you missing out?
  • Davies Collison Cave
  • Asia-Pacific, Australia, New Zealand
  • June 5 2015

Knowing the facts about patent term extension and data exclusivity will ensure you are not missing out on the protection your pharmaceutical product